Open access · CC-BY
via OpenAlex
Targeting of Protein Persulfidation in Aging and Age-Related Disorders
Martín Hugo, Javier García‐Pardo
Pharmaceutics · 2026
Abstract
Aging is associated with a progressive loss of proteostasis(definition) and increased susceptibility to neurodegenerative and metabolic disorders. Among the molecular mechanisms implicated in these processes, protein persulfidation, a hydrogen sulfide (H2S)-mediated cysteine modification, has emerged as a critical regulator of protein function and redox homeostasis. Recent studies demonstrate that aging is accompanied by a decline in persulfidation and a concomitant increase in irreversible cysteine hyperoxidation, leading to protein dysfunction and aggregation. Beyond its established role in protecting proteins from oxidative damage, persulfidation has recently been shown to regulate biomolecular condensation and liquid–liquid phase separation, suppressing the formation of pathological protein assemblies linked to aging and neurodegenerative diseases. Moreover, pharmacological approaches that enhance persulfidation, including stimulation of endogenous H2S production and treatment with ergothioneine, improve metabolic resilience, increase NAD+ levels, and promote healthspan(definition) in experimental models. In this review, we discuss emerging evidence linking loss of persulfidation to protein aggregation, biomolecular condensates, and age-related functional decline, and highlight therapeutic strategies aimed at restoring persulfidation as a promising avenue for healthy aging and disease intervention.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.3390/pharmaceutics18101266
- Canonical
- link ↗
- Fetched
- 2026-10-09 MST
Cite this
APA
Hugo, M., & García‐Pardo, J. (2026). Targeting of Protein Persulfidation in Aging and Age-Related Disorders. <em>Pharmaceutics</em>. https://doi.org/10.3390/pharmaceutics18101266
Vancouver
Hugo M, García‐Pardo J. Targeting of Protein Persulfidation in Aging and Age-Related Disorders. Pharmaceutics. 2026. doi:10.3390/pharmaceutics18101266.
BibTeX
@article{martn2026Target,
title = {Targeting of Protein Persulfidation in Aging and Age-Related Disorders},
author = {Martín Hugo and Javier García‐Pardo},
journal = {Pharmaceutics},
year = {2026},
doi = {10.3390/pharmaceutics18101266},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Pharmaceutics 2026
Open access · OA
Targeting of Protein Persulfidation in Aging and Age-Related Disorders.
Pharmaceutics 2026
Open access · OA
Targeting of Protein Persulfidation in Aging and Age-Related Disorders
Frontiers in Aging Neuroscience 2021
Open access · CC-BY
The Role of Protein Persulfidation in Brain Aging and Neurodegeneration
Free radical biology & medicine 2026
Citation only
Redox resilience in skeletal muscle aging: cellular adaptations and exercise-mediated homeostasis.
Oxidative Medicine and Cellular Longevity 2016
Open access · CC-BY
Mitochondrial Health in Aging and Age‐Related Metabolic Disease
Neurotherapeutics 2025
Open access · CC-BY